Stifel Financial Corp Veru Inc. Transaction History

Stifel Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.76 - $1.79 $15,200 - $35,800	20,000 New	20,000 $16,000
Q4 2021 Feb 14, 2022	SELL	$5.89 - $9.73 $71,858 - $118,706	-12,200 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.78 - $9.89 $20,340 - $29,670	-3,000 Reduced 19.74%	12,200 $104,000
Q2 2021 Aug 13, 2021	BUY	$7.24 - $11.2 $9,412 - $14,559	1,300 Added 9.35%	15,200 $123,000
Q1 2021 May 14, 2021	BUY	$8.05 - $20.78 $111,895 - $288,842	13,900 New	13,900 $150,000

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $204M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.